US lawmakers launch investigation into FDA approval and price of new Alzheimer's drug
by from CNN.com - RSS Channel - App International Edition on (#5KPEA)
Two House committees have launched an investigation into the approval and pricing of the Alzheimer's disease drug aducanumab, made by the company Biogen and sold under the brand name Aduhelm.